Eat Away Pulmonary Fibrosis Scar Tissue:
A New Approach How Is Idiopathic Pulmonary Fibrosis Diagnosed? What is Pulmonary Fibrosis? Video Education
Pulmonary Fibrosis literally means lung (pulmonary) scarring (fibrosis). The lung scarring occurs in the tissue of the lung called the interstitium, which supports the structures of the lung (air sacs/alveoli). There are an estimated 130-200 related diseases called Interstitial Lung Disease that are similar in characteristics and can result in scarring. Pulmonary Fibrosis causes the lung tissue to thicken and become stiff. Scarring inhibits oxygen from entering the blood stream. 2
The Research Behind Enzyme Therapy for Pulmonary Fibrosis Treatment?
Serrapeptase, an signature ingredient in SerraRx80 and Serracor-NK has been in use since 1979. Since then, the effacous anti-inflammatory response with the use of Serrapeptase has been shown not only as new way to eliminate fibrin or fibrous formations in the body systemically, but is showing promising results for chronic inflammation in the lungs along with the dispelling of mucus in the lining of the arterial walls in the lungs. Studies have shown the positive effects of serrrapeptase for the use of Pulmonary Fibrosis and the treatment of many chronic lung conditions.
The ability of Serrapeptase to remove mucous in conditions such as emphysema, Bronchiectasis is a disorder of the airways within the lungs] and bronchitis may also be of interest. A team at the University of Naples evaluated the efficacy and tolerability of Serrapeptase in a multi center, double blind, placebo controlled study of 193 subjects suffering from acute or chronic ear nose or throat disorders. After three or four days significant symptom regression was observed in the Serrapeptase treated patients as compared to placebo.
Serrapeptase appears to be the most useful of all proteolytic enzymes in the treatment of conditions such as Pulmonary Fibrosis. them all. In one study Serrapeptase was compared to trypsin, chymotrypsin, and pronase (another microbial peptidase) in a rat model of scalding, which is known to induce abnormal activation of fibrinolysis. Serrapeptase was far more effective than any other enzyme in reducing fibrosis in this model, in agreement with its documented clinical efficacy as an anti-inflammatory agent.
Serrapeptase, helps immensely as it clears out all of the inflammation, mucus and dead/scar tissue. By clearing away this problem tissue it enables the body’s own healing system to replace it with healthy tissue and better lung function as a result.
Systemic Enzyme Therapy for Pulmonary Fibrosis
What is Systemic Enzyme Therapy?
People must know that the correct medical name for the therapeutic use of natural enzymes is “Systemic Enzyme Therapy.” This means that enzymes flow throughout our bodies, producing the desired healing effects. For an accurate description of Systemic Enzyme Therapy, one needs to know a little bit about the structure and function of enzymes, in general. You must know that without enzymes, there is no possibility of life, in animals, plants or persons. Enzymes are essential for each and every reaction in a living organism.
Enzymes are catalysts, or rather, “biolcatalysts.” We are dealing with determined substances whose presence causes the transformation of an organic substance and it also accelerates it, just as a catalyst would do it. Today we know what these enzymes are and how they act.
At the Program for Studies of Alternative Medicines of the University of Guadalajara (Mexico), we have researched the therapeutic value of these natural proteolytic enzymes in the treatment of acute and chronic clinical conditions such as fibrosis and inflammation. We have had the opportunity of reaffirming that enzymes are catalytically active polymer compounds made of amino acids. They are involved in virtually all of the vital metabolic processes. They set metabolic conversions in track (in train), control energetic processes and regulate syntheses. Without enzymes, nothing goes on at all within an organism.
After many years of experience in analysis and pharmaceutical areas, it was thought that these powerful enzymes could be used in the therapeutic field, too. This way, a new area of enzymatic therapy began. It was applied to alleviate disturbances in the metabolism, that is, impairments in the functions of the organs and to repair genetic faults.
Soon scientists concluded, thanks to these new biochemical tools, that the genetic defects could be corrected or neutralized by means of the application of enzymes. Besides, the genetic defects are enzymatic defects. It has been reported in medical literature that more than 150 diseases are due to enzymatic faults genetically conditioned. This means that the patient’s organism does not form a specific enzyme or it manufactures and places a similar enzyme which has only weak activity. This weak enzyme replaces the right one.
Therefore using systemic enzymes as an alternative approach to reduce fibrosis and scar tissue makes perfect sense. Serrapeptase is a powerful enzyme that comes with a few cautions and far more benefits.
Systemic Enzyme Therapy and its use for Inflammation?
Enzymes are not anti-inflammatory drugs, instead, they promote the inflammation; this is, inflammation is the marvelous response from our body to a noxious stimulus. Most times we look at inflammation as something bad and to be avoided. It should not be so. It is the way our body is trying to get rid of the harmful foreign agents.
The classical signs of inflammation are; pain, tumor, heat and blush. When inflammation ends, the body repairs the area affected. So, if the inflammation finishes sooner, then the repair will begin earlier. That’s the reason enzymes are promoters instead of inhibitors of inflammation.
Systemic enzyme therapy is a proven method; it diminishes the edema, activates the fibrinolytic system, and stimulates cells like macrophages. The pain and the cramps disappear, swelling goes away, and blood flow increases in a short time. The efficacy of certain enzyme mixtures has been tested by double-blind studies.7,8
When searching PubMed for Serrapeptase, one can find close to 40 clinical studies, most of which are from European or Asian researchers, since Serrapeptase has not hit the mainstream in the U.S. The studies, on the whole, conclude that Serrapeptase can have tremendous benefits.
Unlike most Pulmonary Fibrosis treatment options of corticosteroids and surgery, systemic enzymes such as Serracor-NK and Serra Rx80 offer a new alternative approach to such a life threatening condition.
Additional Informative Links that may be of use: